MyFinsight
Home
Blog
About
Contact
Download
Download image
Interest income
$201K
(-40.36%↓ Y/Y)
Net loss
-$9,682K
(0.62%↑ Y/Y)
Total other income
(expense), net
$33K
(102.05%↑ Y/Y)
Product
$4,290K
(25.37%↑ Y/Y)
License And
Collaboration Revenue
$733K
Interest expense
$160K
(-92.74%↓ Y/Y)
Other expense
-$8K
Loss from operations
-$9,715K
(-19.50%↓ Y/Y)
Total revenue
$5,023K
(46.06%↑ Y/Y)
Total operating
expenses
$14,738K
(27.39%↑ Y/Y)
Selling, general and
administrative
$9,989K
(12.90%↑ Y/Y)
Research and development
$3,860K
(69.00%↑ Y/Y)
Cost of product
revenue
$544K
(28.61%↑ Y/Y)
Cost of license and
collaboration revenue
$345K
Back
Back
Income Statement
source: myfinsight.com
Verrica Pharmaceuticals Inc. (VRCA)
Verrica Pharmaceuticals Inc. (VRCA)